# Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels

> **NCT05059873** · PHASE4 · TERMINATED · sponsor: **Capital Medical University** · enrollment: 11 (actual)

## Conditions studied

- Acute Exacerbation of COPD
- Corticosteroid
- Morality
- Lung Diseases, Obstructive
- Blood Eosinophil Count
- COPD
- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05059873
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-05
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-05-31
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Difficulty in recruiting subjects
- **Last updated:** 2024-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05059873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05059873, "Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05059873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*